A SAFETY AND DOSE RANGING STUDY OF IDURSULFASE (INTRATHECAL) ADMINISTRATION VIA AN INTRATHECAL DRUG DELIVERY DEVICE IN PEDIATRIC PATIENTS WITH HUNTER SYNDROME WHO HAVE CENTRAL NERVOUS SYSTEM INVOLVEMENT AND ARE RECEIVING TREATMENT WITH ELAPRASE®: